You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 869 Venetoclax, a specific BCL-2 inhibitor, modulates CAR T cells genetically and functionally during production and augments their anti-tumor response

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
869 Venetoclax, a specific BCL-2 inhibitor, modulates CAR T cells genetically and functionally during production and augments their anti-tumor response

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023118012
Dec 20232605
Jan 20246108
Feb 20242200
Mar 20243605
Apr 20243802
May 20242201
Jun 20244203
Jul 20241602
Aug 20243001
Sep 20245202
Oct 20242208
Nov 202472014
Dec 20243407
Jan 20254208
Feb 2025209
Mar 20250011
Apr 2025003
May 2025004
Jun 2025003
Total6350108